FRACTION: Protocol of a Phase II Study of Fedratinib and Nivolumab Combination in Patients with Myelofibrosis and Resistance or Suboptimal Response to JAK-inhibitor Treatment of the German MPN Study Group (GSG-MPN)
Annals of Hematology（2024）
关键词
Myeloproliferative Neoplasms (MPN),Myelofibrosis (MF),Checkpoint-inhibitor,Fedratinib,Nivolumab,Disease modification
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要